Other Future Targeting Therapy Beyond TNF-amp;#945; Inhibitor in Patients with Spondyloarthropathy

E-ISSN： 1875-6360|5|3|153-157

ISSN： 1573-3971

Source： Current Rheumatology Reviews, Vol.5, Iss.3, 2009-08, pp. : 153-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti Tumor Necrosis Factor Alpha (TNFamp;#945;) Therapy in Ankylosing Spondylitis - Asian Perspective

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor-amp;#945; Therapy in Undifferentiated Spondyloarthritis (USpA)

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 174-176

Bentham Science Publishers

Access to resources Recommend Favorite

Aspects of TNF inhibitor therapy in rheumatoid arthritis

By Nam Jackie Emery Paul

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite

Is there a future role for anti-TNF therapy in cardiovascular disease?

By Jacobsson Lennart TH Jovinge Stefan Turesson Carl

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 265-269

Future Medicine

Access to resources Recommend Favorite

Nef and TNF are Coplayers that Favor HIV-1 Replication in Monocytic Cells and Primary Macrophages

Current HIV Research, Vol. 6, Iss. 2, 2008-03 ,pp. : 117-129

Bentham Science Publishers

Access to resources Recommend Favorite